PRG Science & Technology Co., Ltd.
Clinical Trials
4
Active:0
Completed:1
Trial Phases
3 Phases
Phase 1:1
Phase 2:2
Not Applicable:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (4 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (50.0%)Not Applicable
1 (25.0%)Phase 1
1 (25.0%)Study to Determine Optimal Dose, Evaluate the Efficacy and Safety of PRG-N-01 in Patients With Neurofibromatosis Type II
- First Posted Date
- 2025-08-20
- Last Posted Date
- 2025-08-20
- Lead Sponsor
- PRG Science & Technology Co., Ltd.
- Target Recruit Count
- 25
- Registration Number
- NCT07131722
Study to Determine Optimal Dose and Evaluate Safety, Tolerability, and Pharmacokinetics of Progerinin in Patients with Hutchinson-Gilford Progeria Syndrome (HGPS)
Phase 2
Recruiting
- Conditions
- Hutchinson-Gilford Progeria Syndrome
- Interventions
- First Posted Date
- 2025-01-14
- Last Posted Date
- 2025-01-14
- Lead Sponsor
- PRG Science & Technology Co., Ltd.
- Target Recruit Count
- 16
- Registration Number
- NCT06775041
- Locations
- 🇺🇸
Boston Children's Hospital, Boston, Massachusetts, United States
Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome
- First Posted Date
- 2023-05-06
- Last Posted Date
- 2023-05-06
- Lead Sponsor
- PRG Science & Technology Co., Ltd.
- Target Recruit Count
- 5
- Registration Number
- NCT05847179
Phase I Study of Progerinin in Healthy Volunteers
Phase 1
Completed
- Conditions
- Hutchinson-Gilford Progeria SyndromeWerner Syndrome
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-14
- Last Posted Date
- 2021-09-22
- Lead Sponsor
- PRG Science & Technology Co., Ltd.
- Target Recruit Count
- 64
- Registration Number
- NCT04512963
- Locations
- 🇺🇸
PRG S&T Investigational Site, Glendale, California, United States
News
No news found